Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 901–1,000 of 1,021
Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma
Pan, X., Lu, Y., Huang, J.-L., Long, Y., & Yao, D. (2019) · Aging · doi:10.18632/aging.102429 · Cited by 43
“We used ESTIMATE to output immune scores, which reflected the level of immune cells infiltration into the tumor tissue [9].”
MethodInfluentialPrognostic potential of PRPF3 in hepatocellular carcinoma
Liu, Y., Yang, Y., Luo, Y., Wang, J., Lu, X., Yang, Z., & Yang, J. (2020) · Aging · doi:10.18632/aging.102665 · Cited by 43
“Tumor purity was estimated using ESTIMATE and a consensus approach, as previously described [29, 39].”
MethodPrognostic Value of Tumor-microenvironment-associated Genes in Ovarian Cancer
Li, S., Yao, J., Zhang, S., Zhou, X., Zhao, X., Di, N., Hao, S., & Zhi, H. (2022) · BIO Integration · doi:10.15212/bioi-2022-0008 · Cited by 43
“15212/bioi-2022-0008 The Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm has been proposed to score the fraction of immune and stromal cells in tumor tissues, then predict the infiltration level of immune and stromal cells and tumor purity, on the basis of g…”
MethodAlghamdi, R. A., & Al-Zahrani, M. H. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103596 · Cited by 42
Sigaud, R., Albert, T., Hess, C. C., Hielscher, T., Winkler, N., Kocher, D., Walter, C., Münter, D., Selt, F., Usta, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40235-8 · Cited by 43
“We also included the prediction of immune and stromal in fi ltration in order to evaluate whether the tumor micro-environment could have an impact on the predicted MAPKi sensitivity using the ESTIMATE signatures 68 .”
Molecular classification of urothelial bladder carcinoma
Schwarzova, L., Nováková, Z. V., Danišovič, Ľ., & Žiaran, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08689-7 · Cited by 41
“The stroma-rich subtype is characterized by stromal infiltration [33], intermediate levels of urothelial differentiation, and enrichment in gene signatures representing smooth muscle, endothelium, fibroblasts, and myofibroblasts (Table 2) [14].”
BackgroundLi, L., Li, F., Xu, Z., Li, L., Hu, H., Li, Y., Yu, S., Wang, M., & Gao, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1213891 · Cited by 50
“The results from ESTIMATE indicated that SERPINE1 expression was positively correlated with both the immune score and stromal score in most cancers, especially KIPAN, GBM-LGG, and COAD-READ.”
MethodInfluentialGao, M., Wang, M., Zhou, S., Hou, J., He, W., Shu, Y., & Wang, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03592-y · Cited by 43
Wu, C., Li, H., Hsieh, C., Lin, Y.-T., Chang, I. Y., Chung, A., Huang, Y., Ueng, S., Hsiao, Y.-C., Chien, K., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217482 · Cited by 48
Mutation Drivers of Immunological Responses to Cancer
Porta-Pardo, E., & Godzik, A. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0233 · Cited by 40
“Using ESTIMATE to evaluate tumor immune infiltrate Algorithms that can deduce the cell composition of heterogeneous samples by analysis of gene expression data offer an alternative to direct cell quantification methods and have been benchmarked against methods such as immunostaining or histological analysis (15, 28, 2…”
InfluentialAyers, M., Nebozhyn, M., Cristescu, R., McClanahan, T. K., Perini, R. F., Rubin, E. H., Cheng, J. D., Kaufman, D. R., & Loboda, A. P. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1316 · Cited by 43
“In contrast, other signatures related to tumor cell–intrinsic signaling (23–26), or to distinct types of stromal and myeloid biology (27, 28), were not highly coregulated with PD-L1 (Fig.”
BackgroundMolecular classification of IDH-mutant glioblastomas based on gene expression profiles
Wu, F., Chai, R., Wang, Z., Liu, Y., Zhao, Z., Li, G., & Jiang, H. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz032 · Cited by 41
Varn, F. S., Schaafsma, E., Wang, Y., & Cheng, C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1342 · Cited by 61
Computational approaches for characterizing the tumor immune microenvironment
Liu, C. C., Steen, C. B., & Newman, A. M. (2019) · Immunology · doi:10.1111/imm.13101 · Cited by 45
Endo, E., Okayama, H., Saito, K., Nakajima, S., Yamada, L., Ujiie, D., Kase, K., Fujita, S., Endo, H., Sakamoto, W., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0308 · Cited by 40
“ESTIMATE (estimation of stromal and immune cells in malignant tumor tissues using expression data) scores were calculated using 141 stromal genes and 141 immune genes, respectively, to infer the fraction of stromal cells and immune cells in tumor samples (34).”
MethodLi, F., Guo, H., Wang, Y., Liu, B., & Zhou, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106641 · Cited by 48
Chen, B., Li, L., Li, M., & Wang, X. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00534-4 · Cited by 46
“Tumor purity and stromal content were calculated by ESTIMATE [24].”
MethodSong, Y., Xu, Y., Zhu, X., Fu, J., Deng, C., Chen, H., Xu, H., Song, G., Lu, J., Tang, Q., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01198 · Cited by 44
“To predict and compare the overall level of immune infiltration, we calculated stromal and immune scores by the ESTIMATE algorithm (26).”
MethodZhao, Y., Zhang, M., Pu, H., Guo, S., Zhang, S., & Wang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.585961 · Cited by 48
“The ESTIMATE algorithm was exploited to infer the immune scores for each sample (15).”
MethodShen, E., Han, Y., Cai, C., Liu, P., Chen, Y., Gao, L., Huang, Q., Shen, H., Zeng, S., & He, M. (2021) · Aging · doi:10.18632/aging.202620 · Cited by 43
Self-citationMa, Q., Chen, Y., Xiao, F., Hao, Y., Song, Z., Zhang, J., Okuda, K., Um, S., Silva, M., Shimada, Y., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-223 · Cited by 41
“It integrates the transcriptional profiles of cancer tissues and various infiltrating normal cells (13).”
TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer
Zhang, Z., Hao, R., Guo, Q., Zhang, S., & Wang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.759154 · Cited by 49
“Meanwhile, the ESTIMATE algorithm was applied to assess the immune infiltration levels of BC patients according to the interpretation of gene expression profiles (Yoshihara et al., 2013).”
MethodComprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer
Lou, S., Zhang, J., Yin, X., Zhang, Y., Fang, T., Wang, Y., & Xue, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.782529 · Cited by 58
“6 Estimation of Infiltrating Cells in the GC Microenvironment To quantify the infiltration level of stromal and immune cells in each GC sample, we calculated the stromal and immune scores using the ESTIMATE algorithm (Yoshihara et al., 2013).”
MethodInfluentialDong, K., Chen, W., Pan, X., Wang, H., Sun, Y., Qian, C., Chen, W., Wang, C., Fu, Y., & Cui, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-09251-7 · Cited by 44
“Another study used the pre-established ESTMATE algorithm [42] to assess the genes with prognostic value in the immune microenvironment of ccRCC, identifying FCER1G as a candidate gene [43].”
MethodTuran, T., Kongpachith, S., Halliwill, K. D., Roelands, J. P., Hendrickx, W., Marincola, F. M., Hudson, T. J., Jacob, H. J., Bedognetti, D., Samayoa, J. A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01145-4 · Cited by 43
“ESTIMATE-immune and -stromal signatures were downloaded from the respective publication.(21) The signatures from these sources (83 signatures/predictors) are further filtered due to missing data or outlier behaviour.”
MethodFang, Y., Liu, J., Zhang, Q., She, C., Zheng, R., Zhang, R., Chen, Z., Chen, C., & Wu, J. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02667-2 · Cited by 41
“The Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression (ESTIMATE) algorithm [22] was used to calculate and compare stromal scores, immune scores, and ESTIMATE scores between low and high VDAC1 expression groups of BC samples from TCGA dataset by Wilcoxon rank-sum test.”
MethodReversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma
Lee, P. C., Klaeger, S., Le, P. M., Korthauer, K. D., Cheng, J., Ananthapadmanabhan, V., Frost, T. C., Stevens, J. D., Wong, A. Y. L., Iorgulescu, J. B., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151666 · Cited by 47
“1172/JCI151666 surement of bulk class I expression, we applied ESTIMATE (53) to calculate tumor purity (median 87% purity, range 41%–99%).”
InfluentialYu, H., Chen, C., Han, F., Tang, J., Deng, M., Niu, Y., Lai, M., & Zhang, H. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-1011 · Cited by 43
Jin, L., Mei, W., Liu, X., Sun, X., Xin, S., Zhou, Z., Zhang, J., Zhang, B., Chen, P., Cai, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974034 · Cited by 60
“To identify the TIME difference among three Cuproptosis sub-clusters, Estimation of STromal and Immune cells in Malignant Tumours using Expression data (ESTIMATE) algorithm (24) was executed to computing the Stromal Score, Immune Score and ESTIMATE Score of each cluster.”
MethodChen, H., Yang, W., Xue, X., Li, Y., Jin, Z., & Ji, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415970 · Cited by 44
“Further deciphering the TME showed that Cluster 2 was featured by a high immune/stromal/ESTIMATE score and low tumor purity (Figure 2E).”
MethodWu, Y., Zhan, S., Chen, L., Sun, M., Li, M., Mou, X., Zhang, Z., Xu, L., & Xu, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04381-3 · Cited by 41
“The ESTIMATE method [21] was used to infer the fractions of stromal and immune cells in atrial tissue samples.”
MethodIntegrated genomic analysis of mitochondrial RNA processing in human cancers
Idaghdour, Y., & Hodgkinson, A. (2017) · Genome Medicine · doi:10.1186/s13073-017-0426-0 · Cited by 43
“…on our results we obtained measures of tumor purity and histological estimates of stromal cells and infiltrating lymphocytes from Yoshihara et al. [32] and compared these measures to changes in p9 site methylation levels be-tween matched normal and tumor samples within each cancer type using…”
MethodQi, Y., Chen, D., Lu, Q., Yao, Y., & Ji, C. (2019) · Disease Markers · doi:10.1155/2019/3917040 · Cited by 52
“For evaluating the correlation between risk signature and the immune phenotype of glioma, the ESTIMATE package of R programming language was conducted to calculate the immune score which represented the infiltration of immune cell in the microenvironment of glioma [13].”
MethodHe, Q., Yang, J., & Jin, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869993 · Cited by 52
“Immune Infiltration Analysis The ESTIMATE score was calculated using R package “ESTIMATE” to evaluate the composition of the stromal cells and the immune cells (33).”
Lactate from glycolysis regulates inflammatory macrophage polarization in breast cancer
Wang, C., Xue, L., Zhu, W., Liu, L., Zhang, S., & Luo, D. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03382-x · Cited by 41
“ESTIMATE algorithm was used to calculate the immune score [46].”
MethodLi, H., Yu, M., Zhong, L., Feng, S., Xu, Y., Tang, L., Wu, C. J., Zhang, X., Gu, L., Diao, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162032 · Cited by 43
“The immune and stromal enrichment scores were calculated by ssGSEA with two gene signatures from the study conducted by Yoshihara (30).”
MethodManagement of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic
Lyskjær, I., Iisager, L., Axelsen, C. T., Nielsen, T. K., Dyrskjøt, L., & Fristrup, N. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1892 · Cited by 45
Tanaka, A., Ogawa, M., Zhou, Y., Namba, K., Hendrickson, R. C., Miele, M. M., Li, Z., Klimstra, D. S., Buckley, P. G., Gulcher, J. R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113810 · Cited by 41
Xing, H., Gu, X., Liu, Y., Xu, L., He, Y., & Xue, C. (2024) · Oncogene · doi:10.1038/s41388-024-03184-0 · Cited by 41
“The ssGSEA algorithm in GSVA package [74] was used to analyze the correlation between NSUN2 and immune in fi ltration in pancancer and HCC (using Spearman correlation analysis), and CIBERSORT algorithm [75] was used to analyze the difference in the proportion of major immune cells in HCC patients…”
Weathers, S.-P. S., Li, X., Zhu, H., Damania, A. V., Knafl, M., McKinley, B. A., Lin, H. Y., Harrison, R. A., Majd, N., O'Brien, B. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56930-7 · Cited by 52
“Gene Set Enrichment Analysis (GSEA) performed on the entire set of transcribed genes in each tumor demonstrated a marked enrichment in immune-related genesets associated with a longer OS, notably expression programs associated with interferon gamma and in fl ammatory response, as well as antigen presentation were highl…”
InfluentialThree-dimensional genome landscape of primary human cancers
Yost, K. E., Zhao, Y., Hung, K. L., Zhu, K., Xu, D., Corces, M. R., Shams, S., Louie, B. H., Sarmashghi, S., Sundaram, L., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02188-0 · Cited by 45
Self-citationDNA methylation subgroups in melanoma are associated with proliferative and immunological processes
Lauss, M., Ringnér, M., Karlsson, A., Harbst, K., Busch, C., Geisler, J., Lønning, P. E., Staaf, J., & Jönsson, G. B. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0147-4 · Cited by 42
“Survival analysis was performed using the survival package, principal component analysis was performed using the swamp package [54], ESTIMATE scores were derived using the estimate package [33].”
MethodBradford, J. R., Wappett, M., Beran, G. J., Logié, A., Delpuech, O., Brown, H., Boros, J., Camp, N. J., McEwen, R. K., Mazzola, A. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8014 · Cited by 42
“Stromal phenotype emerges in BTNBC clinical samples of high tumor content As before, we reproduced the tumor purity of the PDX human component in clinical samples by focusing on TCGA samples with the lowest predicted stromal cell content (ESTIMATE stromal score −700).”
BackgroundMethodResultInfluentialPDGFRβ Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas
Kartha, V. K., Stawski, L., Han, R., Haines, P., Gallagher, G. T., Noonan, V. L., Kukuruzinska, M. A., Monti, S., & Trojanowska, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154645 · Cited by 53
“Stroma signature scores based on the ESTIMATE [9] algorithm, pertaining to RNASeqv2 data for HNSC samples were downloaded from http://ibl.mdanderson.org/estimate/.”
MethodInfluentialMathot, P., Grandin, M., Devailly, G., Souazé, F., Cahais, V., Morán, S., Campone, M., Herceg, Z., Esteller, M., Juin, P. P., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.88 · Cited by 40
Zhao, Y., Schaafsma, E., & Cheng, C. (2020) · Cancer Medicine · doi:10.1002/cam4.3284 · Cited by 46
Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
Tang, C., Ma, J., Liu, X., & Liu, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.544610 · Cited by 40
“Evaluation of Immune Cell Infiltration, Tumor Purity, and Matrix Content in BLCA The ESTIMATE algorithm (16) uses transcriptome data to infer the tumor cell composition and infiltration and to identify specific signatures related to the infiltration of stromal cells and immune cells.”
MethodDu, J., Yan, X., Mi, S., Yuan, L., Ji, H., Hou, K., Ma, S., Ba, Y., Zhou, P., Chen, L., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.558961 · Cited by 46
Wang, Y., Yan, K., Lin, J., Liu, Y., Wang, J., Li, X., Li, X., Hua, Z., Zheng, Z., Shi, J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.553399 · Cited by 49
“The Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data (ESTIMATE) is a method that infers the fraction of stromal and immune cells using gene expression signatures (22).”
MethodZeng, F., Li, G., Liu, X., Zhang, K., Huang, H., Jiang, T., & Zhang, Y. (2021) · The Oncologist · doi:10.1002/onco.13750 · Cited by 40
“To learn more about PLAUR in antiglioma immunity, we analyzed the relationship between PLAUR expression and immune cell infiltration in glioma samples by the ESTIMATE algorithm [30].”
MethodGuan, Y., Du, Y., Wang, G., Gou, H., Xue, Y., Xu, J., Li, E., Chan, D. W., Wu, D., Xu, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673295 · Cited by 40
“Analysis of the Immune Score and Stromal Score of the TME ESTIMATE2 (Yoshihara et al., 2013) is a well-established algorithm that generates immune and stromal scores based on RNA-seq data.”
BackgroundLi, X., Cai, H., Cai, Y., Zhang, Q., Ding, Y., & Zhuang, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629854 · Cited by 50
“Identification of Immune Status and Immune-Related DEGs To identify the immune status, the Estimation of Stromal and Immune cells in MAlignant Tumours using Expression data (ESTIMATE) algorithm was applied to identity the infiltration degree of immune cells and predict the immune status (17).”
MethodChen, W., Huang, J., Xiong, J., Fu, P., Chen, C., Liu, Y., Li, Z., Jie, Z., & Cao, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6290261 · Cited by 44
Zhuang, Z., Cai, H., Lin, H., Guan, B., Wu, Y. G., Zhang, Y., Liu, X., Zhuang, J., & Guan, G. (2021) · Journal of Oncology · doi:10.1155/2021/5818512 · Cited by 45
“Estimate, immune, and stromal scores of each patient were calculated with the ESTIMATE algorithm of the “estimate” package [16] to evaluate the difference of immune microenvironment.”
MethodZhang, P., Cao, X., Guan, M., Li, D., Xiang, H., Peng, Q., Zhou, Y., Weng, C., Fang, X., Liu, X., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.76425 · Cited by 46
Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer
Wu, P., Shi, J., Sun, W., & Zhang, H. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02231-0 · Cited by 48
冨松, 京., Metzger, O., Viale, G., Dell’Orto, P., Russo, L., Goyette, M.-A., Kamat, A., Yardley, D. A., Abramson, V. G., Arteaga, C. L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176454 · Cited by 43
“Using the ESTIMATE algorithm (20), we assessed the proportions of immune and stromal components in treat-The J Clin Invest.”
MethodYOD1 serves as a potential prognostic biomarker for pancreatic cancer
Zhang, Z., Zhao, W., Li, Y., Li, Y., Cheng, H., Zheng, L., Sun, X., Liu, H., & Shao, R. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02616-9 · Cited by 39
“Correlation analysis of tumor microenvironment In order to predict whether the increase of YOD1 expression in PAAD patients would affect the tumor microenvironment, we applied the ESTIMATE algorithm to calculate the immune cell score and stromal cell score of each PADD patient in the TCGA database [19].”
MethodFisher, N. C., Byrne, R. M., Leslie, H., Wood, C. S., Legrini, A., Cameron, A. J., Ahmaderaghi, B., Corry, S. M., Malla, S. B., Amirkhah, R., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1102 · Cited by 41
Xiao, G., Li, L., Tanzhu, G., Liu, Z., Gao, X., Wan, X. H., Xiao, D., Chen, L., Xia, X., & Zhou, R. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006243 · Cited by 44
“All tumor slides were stained with antibodies against CD8 (Cat. ab209775, 1:2000, Abcam), Foxp3 (Cat. ab215206, 1:500, Abcam), and CD163 (ZA-0428 Ready- to-Use, ZSGB-BIO).”
Yao, S., Zhao, L., Chen, S., Wang, H., Gao, Y., Shao, N., Dai, M., & Cai, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135657 · Cited by 42
“(29, 30), which is more beneficial for tumor immunotherapy and for determining which patients may benefit from immunotherapy.”
BackgroundZheng, K. C., Hai, Y., Chen, H., Zhang, Y., Hu, X., & Ni, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05186-8 · Cited by 42
“Using the ESTIMATE algorithm [34] to evaluate TME, the immune and stromal scores of High-immu group were significantly higher than the scores of Low-immu group (Additional file 1: Figure S3B).”
MethodRedmer, T., Raigel, M., Sternberg, C., Ziegler, R., Probst, C., Lindner, D., Aufinger, A., Limberger, T., Trachtová, K., Kodajova, P., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02022-x · Cited by 42
Li, L., Zou, J., Pei, S., Huang, W., Zhang, Y., Zhao, Z., Ding, Y., & Xiao, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37726 · Cited by 41
Genomic and transcriptomic landscape of human gastrointestinal stromal tumors
Xie, F., Luo, S., Liu, D., Lu, X., Wang, M., Liu, X., Jia, F., Pang, Y., Shen, Y., Zeng, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53821-1 · Cited by 46
“0.13) based on the gene expression data 86 .”
InfluentialNon-invasive profiling of the tumour microenvironment with spatial ecotypes
Zhang, W., Brown, E. L., Usmani, A., Earland, N. J., Kang, M., Olelewe, C., Viswanathan, A., Chauhan, P. S., Steen, C. B., Jeon, H. S., et al. (2026) · Nature · doi:10.1038/s41586-026-10452-4 · Cited by 50
“Stromal levels were assessed using ESTIMATE (v.1.0.13) 88 .”
InfluentialCheng, J., Guo, Y., Gao, Q., Li, H., Yan, H., Li, M., Cai, H., Zheng, W., Li, X., Jiang, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15754 · Cited by 39
“For the same solid tumor tissue sample (01A) with multiple slide information of ‘percentage of tumor cells’, we used the mean [43] of percentage of tumor cells within multiple slides in performing Spearman correlation analysis and if the information of ‘percentage of tumor cells’ in one of multiple slides was unavaila…”
Method(2017) · Anticancer Research · doi:10.21873/anticanres.11707 · Cited by 39
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation
Foth, M., Ismail, N. F., Kung, J. S. C., Tomlinson, D. C., Knowles, M. A., Eriksson, P., Sjödahl, G., Salmond, J. M., Sansom, O. J., & Iwata, T. (2018) · The Journal of Pathology · doi:10.1002/path.5143 · Cited by 39
“Here, we stratified TCGA data [7] by FGFR3 mutation status and compared the immune gene expression signature [42].”
MethodSandberg, T. P., Oosting, J., van Pelt, G. W., Mesker, W. E., Tollenaar, R. A. E. M., & Morreau, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25845 · Cited by 38
“As with the ESTIMATE genes, there was no significant difference in quantity of immune cells between the stroma-high and -low groups, except for cells of the monocytic lineage like macrophages (t-test = –2.477, p = 0.0203).”
MethodInfluentialCCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
Zhou, Q., Qi, Y., Wang, Z., Zeng, H., Zhang, H., Liu, Z., Huang, Q., Xiong, Y., Wang, J., Chang, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000228 · Cited by 44
Exploring TCGA database for identification of potential prognostic genes in stomach adenocarcinoma
Zhou, L., Huang, W., Yu, H., Feng, Y., & Teng, X. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01351-3 · Cited by 51
“In this algorithm, the authors obtained immune and stromal scores to predict the TME by calculating the expression characteristics of specific molecular biomarkers in immune and stromal cells [17].”
MethodVeeraraghavan, H., Vargas, H., Jiménez-Sánchez, A., Miccò, M., Mema, E., Lakhman, Y., Crispin‐Ortuzar, M., Huang, E. P., Levine, D. A., Grisham, R. N., et al. (2020) · Cancers · doi:10.3390/cancers12113403 · Cited by 45
“The estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) method [27] was used to quantify the immune and stromal signatures from the bulk tumor RNA-sequence data.”
MethodSelf-citationWang, Y., Yan, K., Wang, J., Lin, J., & Bi, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.609334 · Cited by 39
“In addition, we calculated the TMB and tumor purity in TCGA samples, and explored the correlations between macrophage-related factors, TMB, and tumor purity (21).”
MethodGuo, C., Tang, Y., Zhang, Y., & Li, G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.645388 · Cited by 45
Zhao, W., Ou, G., & Lin, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682415 · Cited by 47
“Then, we further analyzed the correlation between NRGs expression and ImmuneScore, ESTIMATEScore and StromalScore of LGG and GBM calculated with R package ESTIMATED (32).”
MethodBai, D., Feng, H., Yang, J., Yin, A., Lin, X., Qian, A., & Sugiyama, H. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.05.009 · Cited by 46
Chua, K. P., Teng, Y. H. F., Tan, A. C., Takano, A. M., Alvarez, J. J. S., Nahar, R. R., Rohatgi, N., Lai, G. G. Y., Aung, Z. W., Yeong, J. P.-S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4607 · Cited by 41
“To obtain purities with less bias, we estimated purities of each tumor using RNA-seq data with ESTIMATE (34) in addition to the SNP-array–based ASCAT and exome-based Sequenza (described above).”
MethodEffects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma
Lv, L., Zhang, Y., Zhao, Y., Wei, Q., Zhao, Y., & Yi, Q. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.704344 · Cited by 47
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients
Zheng, J., Guo, J., Zhu, L., Zhou, Y., & Tong, J. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00881-2 · Cited by 41
“represent the presence of stroma and immune cells [24].”
BackgroundLiu, H., Xu, R., Gao, C., Zhu, T., Liu, L., Yang, Y., Zeng, H., Huang, Y., & Wang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.755668 · Cited by 41
“Alternatively, the level of immune and stromal fraction was scored by Estimation of Stromal Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) based on log2-transformed TPM data, and samples were further divided into high- and lowimmune infiltration groups equally with the cutoff score set at med…”
MethodLiu, J., Geng, R., Yang, S., Shao, F., Zhong, Z., Yang, M., Ni, S., Cai, L., & Bai, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.788431 · Cited by 42
“Immune scores, stromal scores, and estimate scores of each sample were received based on the “Estimation of Stromal and Immune cells in Malignant Tumors using Expression data” (ESTIMATE) algorithm (30).”
MethodImmunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability
Cleyle, J., Hardy, M., Minati, R., Courcelles, M., Durette, C., Lanoix, J., Laverdure, J., Vincent, K., Perreault, C., & Thibault, P. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100228 · Cited by 43
“Next, we estimated the degree of immune in fi ltration of each sample via two independent approaches using the immune in fi ltration score from the ESTIMATE package (38) (Fig.”
Song, Q., Ye, Y., Jiang, D., Qin, Z., Xu, C., Wang, H., Huang, J., Chen, L., Luo, R., Zhang, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31719-0 · Cited by 42
Chen, J., Li, H., Qian, X., Lin, L., Pan, Y., & Han, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948601 · Cited by 43
“The immune and stromal cell sores were calculated by estimate (43).”
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment
Papadas, A., Deb, G., Cicala, A., Officer, A., Hope, C. L., Pagenkopf, A. C., Flietner, E. D., Morrow, Z. T., Emmerich, P. B., Wiesner, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111201 · Cited by 49
Zhang, Z., Wiencke, J. K., Kelsey, K. T., Koestler, D. C., Christensen, B. C., & Salas, L. A. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03736-6 · Cited by 53
“…methods, including methylation-based InfiniumPurify [19] , MethylCIBERSORT [17] , Meth-ylResolver [16] , LUMP [23] , gene expression-based ESTIMATE [24] , somatic copy-number-based ABSO-LUTE [25] , image stain-based IHC [26] , and a consensus measurement of purity estimations (CPE) [26], using…”
MethodSpatially Resolved Transcriptomics Technology Facilitates Cancer Research
Wang, Q., Zhi, Y., Zi, M., Mo, Y., Wang, Y., Liao, Q., Zhang, S., Gong, Z., Wang, F., Zeng, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202302558 · Cited by 45
METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Jiang, Z., Yin, W., Zhu, H., Tan, J., Guo, Y., Xin, Z., Zhou, Q., Cao, Y., Wu, Z., Kuang, Y., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02087-4 · Cited by 38
“It can be inferred by analyzing the ESTIMATE score [28].”
MethodGed, Y. M. A., Sánchez, A., Patil, S., Knežević, A., Stein, E., Petruzella, S., Weiss, K. L., Düzgöl, C., Chaim, J. L., Akın, O., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1389 · Cited by 39
Zhou, H., Jing, S., Liu, Y., Wang, X., Duan, X., Xiong, W. G., Li, R., Peng, Y., Ai, Y., Fu, D., et al. (2022) · Cell Proliferation · doi:10.1111/cpr.13373 · Cited by 40
“The algorithm ESTIMATE provides stromal, immune, and ESTIMATE scores by performing ‘limma’ and ‘estimate’ with TCGA-STAD data.(25) To estimate the definitive proportions of two types of stromal cells and eight types of immune cells”
MethodWolf, M. M., Rathmell, W. K., & de Cubas, A. A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00700-5 · Cited by 39
PUREE: accurate pan-cancer tumor purity estimation from gene expression data
Revkov, E., Kulshrestha, T., Sung, K. W.-K., & Skanderup, A. J. (2023) · Communications Biology · doi:10.1038/s42003-023-04764-8 · Cited by 43
“ESTIMATE calculates a combined enrichment score for in fi ltrating immune and stromal cells followed by training of a supervised model 28 .”
MethodDeng, C., Deng, G., Chu, H., Chen, S., Chen, X., Li, X., He, Y., Sun, C., & Zhang, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140328 · Cited by 38
“The Estimation of Stromal and Immune cells in Malignant Tumours using Expression data (ESTIMATE) algorithm was employed to calculate the scores of stromal cells, immune cells and tumor cells in the different hypoxia score groups (14).”
MethodXia, H., Zhang, H., Ruan, Z., Zhang, H., Sun, L., Chen, H., Zhou, Y., Zhang, L., Bian, D., Zhu, X., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01861-w · Cited by 44
Huang, Z., Li, Y., Liu, Q., Chen, X., Lin, W., Wu, W., Chen, Z., Chen, X., Pan, Y., & Qiu, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113944 · Cited by 42
CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis
Hutchenreuther, J., Vincent, K. M., Carter, D. E., Postovit, L.-M. M., & Leask, A. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.279 · Cited by 42
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
Arbab, A. S., & Achyut, B. R. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s102907 · Cited by 45
Jungk, C., Möck, A., Exner, J., Geisenberger, C., Warta, R., Capper, D., Abdollahi, A., Friauf, S., Lahrmann, B., Grabe, N., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0710-7 · Cited by 40
“[20], as described in detail in Additional file 1: Figure S1B–D and Additional file 2.”
MethodExploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment
Li, M., Liu, Z., & Wang, X. (2018) · Journal of Oncology · doi:10.1155/2018/3979527 · Cited by 40
“In addition, we assessed the levels of immune infiltration in cancers by the ESTIMATE algorithm [18].”
Method
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.